Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BioChip Labs
AddedFeb 19, 2024
UpdatedJun 18, 2026
BioChip Labs

BioChip Labs

Angel

Biochip Labs, a CLIA-certified lab in Ohio, specializes in blood disorder testing since 2019.

HQ
Cleveland, OH, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded in 2019 and headquartered in Cleveland, Ohio, BioChip Labs is a CLIA-certified laboratory specializing in blood disorder testing. The company's core mission is to provide accurate and high-quality diagnostic assays for conditions like sickle cell disease and thalassemia. BioChip Labs serves a diverse market that includes clinicians, researchers, clinical care centers, pharmaceutical companies, and other laboratories.

BioChip Labs has established itself as a key player in the diagnostic field, leveraging advanced biomarker assays to deliver reliable results. Notable affiliated individuals include leading researchers and clinicians in hematology. The company has achieved significant milestones in improving diagnostic accuracy and patient care for blood disorders, making a substantial impact on both clinical outcomes and research advancements.

BioChip Labs - Similar Companies

Liquid Biotech logo

Liquid Biotech

DotLab logo

DotLab

dotlab.com

BioAnalytics logo

BioAnalytics

FloBio logo

FloBio

flobiollc.com

Lab Me Analytics logo

Lab Me Analytics

labme.ai

Babson Diagnostics logo

Babson Diagnostics

babsondx.com

Ischemia Care logo

Ischemia Care

ischemiacare.com

Cellia Science logo

Cellia Science

celliasci.com

FBB Biomed logo

FBB Biomed

fbbbio.com

Biovision Diagnostics logo

Biovision Diagnostics

biovisiondx.com

Correlia Biosystems logo

Correlia Biosystems

Biorosa Technologies logo

Biorosa Technologies

biorosa.com

Labs on the Go logo

Labs on the Go

Valtari Bio logo

Valtari Bio

Moleculera Labs logo

Moleculera Labs

moleculera.com

BioChip Labs - Quick Facts

Who are BioChip Labs' competitors?

Companies similar to BioChip Labs include Liquid Biotech, DotLab, BioAnalytics and FloBio.

When was BioChip Labs founded?

BioChip Labs was founded in 2019.

Where is BioChip Labs' headquarters located?

BioChip Labs' headquarters is located in Cleveland, OH, US.

When was BioChip Labs' last funding round?

BioChip Labs' most recent funding round was for $150k (USD) in July 2023.

How much has BioChip Labs raised to-date?

As of Jul 11, 2023, BioChip Labs has raised a total of $406k (USD).

How many employees does BioChip Labs have?

BioChip Labs has 8 employees as of Feb 4, 2024.

BioChip Labs - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Blood Testing
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 9 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified